Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Paratus Diagnostics was a medical technology company based in Austin, Texas, that specialized in point-of-care (POC) diagnostic solutions for infectious diseases. The company's core technology was the Preparedness and Response (PAR) System, a portable platform designed to provide rapid, lab-quality results in clinical settings using proprietary cartridge-based assays. Their lead product, a rapid Strep A test, achieved FDA 510(k) clearance and a CLIA waiver, targeting the decentralized testing market. Despite its technological advancements in microfluidics and pathogen detection, the company is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Paratus Diagnostics.